Literature DB >> 1928019

A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy.

K M Carroll1, B J Rounsaville, F H Gawin.   

Abstract

Despite the widespread use of psychotherapy as treatment for cocaine abuse, the effectiveness of psychotherapy has not been explored through clinical trials. Forty-two outpatients who met DSM-III criteria for cocaine abuse were randomly assigned to one of two forms of purely psychotherapeutic treatments of cocaine abuse, either relapse prevention (RPT) or interpersonal psychotherapy (IPT). Subjects assigned to relapse prevention were more likely than subjects in IPT to attain three or more continuous weeks of abstinence (57 versus 33%), be classified as recovered at the point of treatment termination (43 versus 19%), and complete treatment (67 versus 38%). Whereas these differences did not reach statistical significance, significant differences by treatment group did emerge when subjects were stratified by severity of substance use: Among the subgroup of more severe users, subjects who received RPT were significantly more likely to achieve abstinence (54 versus 9%) and be classified as recovered (54 versus 0%). Among the subgroups of subjects with lower severity of substance abuse, outcome was comparable for both treatment types. Comparison of results from this investigation with historical controls from a structurally similar pharmacotherapy trial suggests that purely psychotherapeutic treatments may be both viable and effective approaches for many ambulatory cocaine abusers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928019     DOI: 10.3109/00952999109027549

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  25 in total

1.  Interpersonal psychotherapy: principles and applications.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

Review 2.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

3.  Gender differences in substance use treatment entry and retention among prisoners with substance use histories.

Authors:  Bernadette Pelissier
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

4.  Pilot study of treatment for major depression among women prisoners with substance use disorder.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Psychiatr Res       Date:  2012-06-12       Impact factor: 4.791

Review 5.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

Review 6.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

7.  Drug assertiveness and sexual risk-taking behavior in a sample of HIV-positive, methamphetamine-using men who have sex with men.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; John R McQuaid; Thomas L Patterson
Journal:  J Subst Abuse Treat       Date:  2011-05-08

8.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

9.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

10.  Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

Authors:  Joy M Schmitz; Marc E Mooney; F Gerard Moeller; Angela L Stotts; Charles Green; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2007-12-27       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.